Apoptosis of T lymphocytes invading glioblastomas multiforme: a possible tumor defense mechanism.
about
Overview of current immunotherapeutic strategies for gliomaSingle vs. combination immunotherapeutic strategies for glioma.FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors.All in the head: obstacles for immune rejection of brain tumours.Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma.GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway.Cytokine gene therapy for malignant glioma.Memory T cells in human tumor and chronic inflammatory microenvironments: sleeping beauties re-awakened by a cytokine kiss.Immunotherapeutic approaches for gliomaThe molecular profile of microglia under the influence of glioma.Achieving graft-versus-tumor effect in brain tumor patients: from autologous progenitor cell transplant to active immunotherapy.Combining immunotherapy with radiation for the treatment of glioblastoma.Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy.Site-specific anti-tumor immunity: differences in DC function, TGF-beta production and numbers of intratumoral Foxp3+ Treg.Tumor-associated macrophages in glioma: friend or foe?Ménage à trois: Sustained therapeutic anti-tumor immunity requires multiple partners in malignant glioma.FasL gene knock-down therapy enhances the antiglioma immune response.When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.T-Cell Dysfunction in Glioblastoma: Applying a New Framework.
P2860
Q26776345-5B6AE14A-2919-4E7F-B25D-764D8A5EBE3BQ33746041-8A09B5E8-ADE2-404E-8239-892BD5E5132FQ34243615-690C9423-9967-4796-9A83-426CC6BED5C4Q34842204-ED95F0A5-BDB0-4E0C-99DD-7ECED1064B1FQ35045473-55B176B3-C431-4EB6-BC27-17DAF783293DQ35726496-88FAB6D5-DDAE-4C2D-A620-9D4C369AC3EAQ35907022-A54C5A5A-B71F-489E-B1B4-810C5F5EA92DQ36569011-15D43ADB-CD15-47CB-AA41-309BB21C3A48Q37267793-6A7A3417-035C-41B3-A7BC-7A99F0906562Q38008966-6F8B8A9F-0CBA-439C-B035-0F4415422849Q38063583-0C8C1279-6FF6-42AD-86A7-DEC95691FDCCQ38422623-7771AF96-98C1-445B-BC0E-1CAD2DE0F0B9Q38989773-2C0C7507-90AD-4B70-8B57-362F99807319Q39865711-D4770FA7-9233-41DB-B1F7-188D15F2E7E7Q41062315-341CDB66-85BE-4CCA-A5DA-1C5E32B00DC5Q42027168-4EFD94E4-7CFC-4F60-B54F-F50EEC899BCDQ42425989-D3C1694B-9FFE-4E37-B781-8E85B9FF7E83Q47826206-CF79C32E-4A92-4E17-90CD-8875A7C48980Q52625023-450A980F-8EAE-4438-B094-84E942C72355
P2860
Apoptosis of T lymphocytes invading glioblastomas multiforme: a possible tumor defense mechanism.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Apoptosis of T lymphocytes inv ...... sible tumor defense mechanism.
@ast
Apoptosis of T lymphocytes inv ...... sible tumor defense mechanism.
@en
type
label
Apoptosis of T lymphocytes inv ...... sible tumor defense mechanism.
@ast
Apoptosis of T lymphocytes inv ...... sible tumor defense mechanism.
@en
prefLabel
Apoptosis of T lymphocytes inv ...... sible tumor defense mechanism.
@ast
Apoptosis of T lymphocytes inv ...... sible tumor defense mechanism.
@en
P2093
P2860
P1476
Apoptosis of T lymphocytes inv ...... sible tumor defense mechanism.
@en
P2093
Candace Minchew
David S Baskin
Vladimir V Didenko
P2860
P304
P356
10.3171/JNS.2002.96.3.0580
P577
2002-03-01T00:00:00Z